AR087539A1 - ELECTROLYTIC FORMULATION READY FOR USE, BAG READY FOR USE, KIT, USES AND RENAL INSUFFICIENCY TREATMENT METHOD - Google Patents

ELECTROLYTIC FORMULATION READY FOR USE, BAG READY FOR USE, KIT, USES AND RENAL INSUFFICIENCY TREATMENT METHOD

Info

Publication number
AR087539A1
AR087539A1 ARP120102980A ARP120102980A AR087539A1 AR 087539 A1 AR087539 A1 AR 087539A1 AR P120102980 A ARP120102980 A AR P120102980A AR P120102980 A ARP120102980 A AR P120102980A AR 087539 A1 AR087539 A1 AR 087539A1
Authority
AR
Argentina
Prior art keywords
ready
kit
bag
treatment method
electrolytic
Prior art date
Application number
ARP120102980A
Other languages
Spanish (es)
Inventor
Billi Maurizio
Original Assignee
Eurofarma Lab S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurofarma Lab S A filed Critical Eurofarma Lab S A
Publication of AR087539A1 publication Critical patent/AR087539A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)

Abstract

Reivindicación 1: Formulación electrolítica lista para su uso, caracterizada por contener sulfato de magnesio, por lo menos otro electrolito y vehículos apropiados. Reivindicación 3: Formulación electrolítica lista para su uso, de acuerdo con la reivindicación 1, caracterizada por el hecho de que dicho otro electrolito es seleccionado entre cloruro de sodio, cloruro de potasio, cloruro de calcio, cloruro de magnesio, acetatos, carbonatos, fosfatos y bicarbonatos. Reivindicación 4: Formulación electrolítica lista para su uso, de acuerdo con la reivindicación 1, caracterizada por el hecho de que dicho vehículo es agua. Reivindicación 11: Bolsa lista para su uso, de acuerdo con la reivindicación 9, caracterizada por el hecho de estar constituida de un material seleccionado de polipropileno (PP), cloruro de polivinilo (PVC), copolímeros de etileno-acetato de vinilo (EVA), diclorhidrato de polivinilo, y lo similar.Claim 1: Ready-to-use electrolytic formulation, characterized in that it contains magnesium sulfate, at least one other electrolyte and appropriate vehicles. Claim 3: Electrolytic formulation ready for use, according to claim 1, characterized in that said other electrolyte is selected from sodium chloride, potassium chloride, calcium chloride, magnesium chloride, acetates, carbonates, phosphates and bicarbonates. Claim 4: Electrolytic formulation ready for use, according to claim 1, characterized in that said vehicle is water. Claim 11: Bag ready for use, according to claim 9, characterized in that it consists of a material selected from polypropylene (PP), polyvinyl chloride (PVC), ethylene-vinyl acetate (EVA) copolymers , polyvinyl dihydrochloride, and the like.

ARP120102980A 2011-08-25 2012-08-14 ELECTROLYTIC FORMULATION READY FOR USE, BAG READY FOR USE, KIT, USES AND RENAL INSUFFICIENCY TREATMENT METHOD AR087539A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI1104153-6A BRPI1104153A2 (en) 2011-08-25 2011-08-25 Ready-to-use electrolyte formulation, ready-to-use pouch, kit, uses and method of treating renal failure

Publications (1)

Publication Number Publication Date
AR087539A1 true AR087539A1 (en) 2014-04-03

Family

ID=47745788

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120102980A AR087539A1 (en) 2011-08-25 2012-08-14 ELECTROLYTIC FORMULATION READY FOR USE, BAG READY FOR USE, KIT, USES AND RENAL INSUFFICIENCY TREATMENT METHOD

Country Status (4)

Country Link
AR (1) AR087539A1 (en)
BR (1) BRPI1104153A2 (en)
UY (1) UY34288A (en)
WO (1) WO2013026118A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8105258B2 (en) * 1999-04-26 2012-01-31 Baxter International Inc. Citrate anticoagulation system for extracorporeal blood treatments
DE102004023828A1 (en) * 2004-05-13 2005-12-08 Fresenius Medical Care Deutschland Gmbh Solution for peritoneal dialysis
BRPI0603854A (en) * 2006-08-30 2007-04-17 Sociedade Benef Israelita Bras solution for replacement of lost electrolytes during dialysis procedure in patients with acute kidney disease
BRPI0603844A (en) * 2006-08-30 2007-04-17 Sociedade Benef Israelita Bras diallytic solution applied to patients with acute kidney disease
CN101912414A (en) * 2010-08-20 2010-12-15 宋青 Blood purification base displacing liquid

Also Published As

Publication number Publication date
BRPI1104153A2 (en) 2015-08-25
UY34288A (en) 2013-04-05
WO2013026118A1 (en) 2013-02-28

Similar Documents

Publication Publication Date Title
GEP20156421B (en) Insert for vapor-permeable and waterproof soles
EP4056283A3 (en) Collector for mineral flotation and use therof
WO2014151718A3 (en) Water-soluble film for delayed release
GB201211995D0 (en) De-icer and/or anti-icer compostions and methods
UA106767C2 (en) An insert for water-proof and vapor-permeable shoes
WO2014031852A3 (en) Blood storage container containing aqueous composition for the storage of red blood cells
GB2473447B (en) Tile and tile holding device
BR112015012008A2 (en) shark barrier
EA201291170A1 (en) SPECIFIC SYSTEMS WITH LOW CONTENTS OF SURFACE-ACTIVE SUBSTANCES OF SOFT ACTION, WITH HIGH CONTENTS OF RELAXING MEANS, WHICH REMAIN THE FOAMING AND THE PHASE OF THIS
BR112016018360A2 (en) REACTIVE COMPOSITION, PROCESSES FOR PRODUCING A COMPOSITION AND FOR PURIFICATION OF A FLUE GAS, AND USE OF A COMPOUND
EA200801606A1 (en) PRELIMINARY MOISTENED ANTICOLANT COMPOSITION WITH STABILIZED SATURATION
AR060264A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING LACTATE AND CALCIUM, USES OF SUCH COMPOSITION AND PREPARATION METHOD
MX2018007112A (en) Fast dissolving peroxymonosulfate composition.
MX336387B (en) Anhydrous antiperspirant compositions.
AR102441A1 (en) FOOD CONCENTRATE
AR087539A1 (en) ELECTROLYTIC FORMULATION READY FOR USE, BAG READY FOR USE, KIT, USES AND RENAL INSUFFICIENCY TREATMENT METHOD
EA201791670A1 (en) HARD COMPOSITIONS FOR CARE OF THE ORAL CAVITY
PE20151085A1 (en) COMPOSITION OF XANTOFILAS
CL2012000371A1 (en) Composition capable of swelling in salt water comprising a smectite clay, acrylamide copolymer, elastomeric resin, cationic flocculant and primary plasticizer for the elastomeric resin; method of waterproofing a surface; sealed concrete structure; and a saltwater barrier article.
EP3023639A3 (en) System for water supply using sunlight
SV2006002223A (en) PHARMACEUTICAL COMPOSITION REF. BHCO41369-SV
PE20141366A1 (en) CONTROLLED RELEASE SYSTEM AND USES OF THE SAME
EP3593650A3 (en) Preparations capable of increasing the ph of food by releasing molecular hydrogen
RU2009126331A (en) CRYSTALLOID CARDIOPLEGIC SOLUTION
PE20151432A1 (en) SUSTAINED RELEASE LORAZEPAM FORMULATIONS

Legal Events

Date Code Title Description
FB Suspension of granting procedure